US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US20010003001A1
(en)
|
1993-04-22 |
2001-06-07 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6610329B2
(en)
|
1993-04-22 |
2003-08-26 |
Emisphere Technologies Inc. |
Compositions for the delivery of antigens
|
JP3628713B2
(ja)
*
|
1993-06-07 |
2005-03-16 |
帝國製薬株式会社 |
生理学的に活性なペプチドを含有する膣投与製剤
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
FR2735131B1
(fr)
*
|
1995-06-12 |
1997-08-22 |
Rech De Pathologie Appliquee S |
Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament
|
US5766620A
(en)
*
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
US5912014A
(en)
*
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
SI9720025A
(sl)
|
1996-03-29 |
1999-08-31 |
Emishphere Technologies, Inc. |
Spojine in sestavki za prenos aktivne snovi
|
JP2000512671A
(ja)
|
1996-06-14 |
2000-09-26 |
エミスフェアー テクノロジーズ インク |
マイクロカプセル化香料及び調製方法
|
EP0886471A4
(en)
|
1996-11-18 |
2002-07-17 |
Emisphere Tech Inc |
METHODS AND COMPOSITIONS FOR INDUCING ORAL TOLERANCE IN MUZZLES
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP0983769A4
(en)
*
|
1997-04-14 |
2002-05-02 |
Mitsubishi Tokyo Pharm Inc |
PERMUCOSE FORMULATION
|
EP0880969A1
(en)
*
|
1997-05-28 |
1998-12-02 |
Applied Research Systems ARS Holdings N.V. |
Pharmaceutical compositions of peptides having low solubility in physiological medium
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
ATE277949T1
(de)
*
|
1998-07-21 |
2004-10-15 |
Monsanto Technology Llc |
Klärung von protein-niederschlagsuspensionen durch verwendung von anionischen polymerischen flockungsmitteln
|
JP4675481B2
(ja)
|
1998-07-27 |
2011-04-20 |
エミスフェアー・テクノロジーズ・インク |
活性剤の肺性デリバリー
|
US6440929B1
(en)
|
1998-07-27 |
2002-08-27 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
EP1102742B1
(en)
|
1998-08-07 |
2006-06-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
AU1031500A
(en)
*
|
1998-11-03 |
2000-05-22 |
Dandy A/S |
Sucrose fatty acid esters for use as increased release of active ingredients
|
AU2681300A
(en)
*
|
1999-02-22 |
2000-09-14 |
Elan Corporation, Plc |
Solid oral dosage form containing an enhancer
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
US8119159B2
(en)
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
AU4216700A
(en)
|
1999-04-05 |
2000-10-23 |
Emisphere Technologies, Inc. |
Disodium salts, monohydrates, and ethanol solvates
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
PT1196430E
(pt)
*
|
1999-06-29 |
2012-04-18 |
Mannkind Corp |
Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
|
US7279597B1
(en)
|
1999-11-05 |
2007-10-09 |
Emisphere Technologies, Inc. |
Phenyl amine carboxylic acid compounds and compositions for delivering active agents
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
WO2001044199A1
(en)
|
1999-12-16 |
2001-06-21 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
AT409081B
(de)
*
|
2000-02-16 |
2002-05-27 |
Gebro Pharma Gmbh |
Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
|
EP1390383B1
(en)
|
2001-05-11 |
2012-02-29 |
Isis Pharmaceuticals, Inc. |
Antisense permeation enhancers
|
CA2479751C
(en)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Inhalation apparatus
|
DE60307082D1
(de)
*
|
2002-05-07 |
2006-09-07 |
Ferring Bv |
In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
|
GB0210397D0
(en)
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
GB0221712D0
(en)
*
|
2002-09-19 |
2002-10-30 |
Ardana Bioscience Ltd |
Methods of treatment
|
JP2006510656A
(ja)
*
|
2002-12-11 |
2006-03-30 |
チョン・クン・ダン・ファーマシューティカル・コーポレーション |
吸収されにくい極性薬物の経口用製剤
|
US8088734B2
(en)
|
2003-01-21 |
2012-01-03 |
Unigene Laboratories Inc. |
Oral delivery of peptides
|
BRPI0302736B8
(pt)
*
|
2003-06-02 |
2021-05-25 |
Ems S/A |
composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
PT1530967E
(pt)
|
2003-11-13 |
2006-09-29 |
Ferring Bv |
Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
|
CN101027082A
(zh)
*
|
2004-01-12 |
2007-08-29 |
曼恩坎德公司 |
降低2型糖尿病患者血清胰岛素原水平的方法
|
EP1711220A1
(en)
*
|
2004-01-16 |
2006-10-18 |
Biodel, Inc. |
Sublingual drug delivery device
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US7279457B2
(en)
*
|
2004-03-12 |
2007-10-09 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
ES2385934T3
(es)
|
2004-08-20 |
2012-08-03 |
Mannkind Corporation |
Catálisis de la síntesis de dicetopiperazina.
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
KR20080039876A
(ko)
*
|
2005-07-22 |
2008-05-07 |
미리어드 제네틱스, 인크. |
높은 약물 충진 제형 및 투여형
|
NZ566489A
(en)
*
|
2005-08-26 |
2008-10-31 |
Action Pharma As |
Therapeutically active alpha-MSH analogues
|
DK1928423T3
(en)
|
2005-09-14 |
2016-02-29 |
Mannkind Corp |
A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US8093207B2
(en)
*
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
US8039431B2
(en)
|
2006-02-22 |
2011-10-18 |
Mannkind Corporation |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
AU2007235251B2
(en)
|
2006-04-07 |
2013-02-07 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
MX2008013165A
(es)
*
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
US8377863B2
(en)
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
ES2319054B1
(es)
|
2007-08-06 |
2010-02-12 |
Gp Pharm S.A. |
Composicion farmaceutica oral de desmopresina.
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
AU2009244799B2
(en)
|
2008-05-07 |
2014-11-20 |
Merrion Research Iii Limited |
Compositions of GnRH related compounds and processes of preparation
|
US20100286045A1
(en)
|
2008-05-21 |
2010-11-11 |
Bjarke Mirner Klein |
Methods comprising desmopressin
|
US11963995B2
(en)
|
2008-05-21 |
2024-04-23 |
Ferring B.V. |
Methods comprising desmopressin
|
PT2712622T
(pt)
|
2008-05-21 |
2016-10-13 |
Ferring Bv |
Desmopressina orodispersível para aumentar o período inicial de sono tranquilo
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
AU2009257311B2
(en)
|
2008-06-13 |
2014-12-04 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
WO2010033726A2
(en)
|
2008-09-17 |
2010-03-25 |
The Brigham And Women's Hospital, Inc. |
Drug delivery composition comprising a self-assembled gelator
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
JP5667095B2
(ja)
|
2009-03-11 |
2015-02-12 |
マンカインド コーポレイション |
吸入器の抵抗を測定するための装置、システムおよび方法
|
US9018190B2
(en)
|
2009-03-27 |
2015-04-28 |
Adocia |
Functionalized oligosaccharides
|
FR2943538B1
(fr)
*
|
2009-03-27 |
2011-05-20 |
Adocia |
Formulation a action rapide d'insuline recombinante humaine
|
CA2764505C
(en)
|
2009-06-12 |
2018-09-25 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
PT4104848T
(pt)
|
2009-06-18 |
2024-01-04 |
Acerus Pharmaceuticals Usa Llc |
Administração segura de desmopressina
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
CA2784120A1
(en)
|
2009-12-16 |
2011-07-14 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
US20110142889A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
US9089484B2
(en)
|
2010-03-26 |
2015-07-28 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
WO2012040623A2
(en)
|
2010-09-24 |
2012-03-29 |
The Brigham And Women's Hospital, Inc. |
Nanostructured gels capable of controlled release of encapsulated agents
|
AU2012204213A1
(en)
|
2011-01-07 |
2013-06-13 |
Merrion Research Iii Limited |
Pharmaceutical compositions of iron for oral administration
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
BR112014006356B1
(pt)
|
2011-09-19 |
2022-01-18 |
Orexo Ab |
Comprimido sublingual, processo para a preparação do mesmo e seu uso
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US20130231281A1
(en)
|
2011-11-02 |
2013-09-05 |
Adocia |
Rapid acting insulin formulation comprising an oligosaccharide
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
CA2889552C
(fr)
|
2012-11-13 |
2023-10-10 |
Adocia |
Formulation a action rapide d'insuline comprenant un compose anionique substitue
|
ES2754388T3
(es)
|
2013-03-15 |
2020-04-17 |
Mannkind Corp |
Composiciones y métodos de dicetopiperazina microcristalina
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
FR3020947B1
(fr)
|
2014-05-14 |
2018-08-31 |
Adocia |
Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
|
US9795678B2
(en)
|
2014-05-14 |
2017-10-24 |
Adocia |
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
KR102294577B1
(ko)
|
2015-01-12 |
2021-08-26 |
엔터리스 바이오파마, 인크. |
고체 경구 제형
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
AU2016335846B2
(en)
|
2015-10-08 |
2019-04-04 |
The Brigham And Women's Hospital, Inc. |
Stabilized assembled nanostructures for delivery of encapsulated agents
|
FR3043557B1
(fr)
|
2015-11-16 |
2019-05-31 |
Adocia |
Composition a action rapide d'insuline comprenant un citrate substitue
|
US10568840B2
(en)
|
2016-05-06 |
2020-02-25 |
The Brigham And Women's Hospital, Inc. |
Self assembled gels for controlled delivery of encapsulated agents to cartilage
|
AU2017305415A1
(en)
|
2016-08-05 |
2019-03-07 |
Enteris Biopharma, Inc. |
Room temperature stable oral calcitonin formulation
|
US11020410B2
(en)
|
2017-02-03 |
2021-06-01 |
The Brigham And Women's Hospital, Inc. |
Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
|
WO2018208822A1
(en)
|
2017-05-08 |
2018-11-15 |
Alivio Therapeutics, Inc. |
Formulation of nanostructured gels for increased agent loading and adhesion
|
WO2019102310A1
(en)
*
|
2017-11-24 |
2019-05-31 |
Alaval (Pty) Ltd |
Vip formulation for management of inflammatory conditions
|
AU2019357859A1
(en)
|
2018-10-11 |
2021-06-03 |
Alivio Therapeutics, Inc. |
Non-injectable hydrogel formulations for smart release
|